Navigation Links
Barnett Releases IND Submissions: A Primer
Date:2/25/2009

Barnett International, a division of Cambridge Healthtech Institute, has announced the release of IND Submissions: A Primer, an in-depth guide to writing, editing, tracking, and submitting the original IND and applicable IND amendments. IND Submissions: A Primer is the only comprehensive IND manual of its kind.

Needham, MA (PRWEB) February 25, 2009 -- IND Submissions: A Primer provides a "hands-on" approach that teaches regulatory professionals - novice and veteran alike - to work with the regulations, guidance documents, content templates, contributing authors, and style guides necessary to write an IND. The book's writing tips show regulatory professionals how to produce a range of U.S. drug and biologics submissions that comply with the requirements and are also clear to read. Included with the book is a CD filled with electronic examples.

The 600-page, spiral-bound, hardcover book is easy to use, providing step-by-step instructions on how to plan, write, and submit regulatory documents. Each chapter (62 in total) is divided by easy-to-read tabs.

IND Submissions: A Primer is the ideal resource for new professionals entering the field, a useful training guide, and a valuable reference for the experienced professional. This comprehensive "how-to" guide contains:

  • Regulations and guidance document references
  • Overview and background of why the submission is required
  • Structure of the submission itself
  • Details on who should contribute to the submission
  • Where to pull, re-use, or start as a basis for information needed in a submission
  • Tips and lessons learned from the author's experience
  • Different perspectives on how a submission can be approached
  • Applicable FDA Form 1571 information for each submission
  • Paper publishing tips
  • Electronic CTD publishing sections for each submission, where applicable
  • Real life examples taken from the press and approved NDAs when available
  • Electronic examples and content templates to utilize so that an RA professional can begin immediately working on a submission

IND Submissions: A Primer is available for $295 per copy by calling 800-856-2556, or by ordering online at www.barnettinternational.com. Estimated shipping date is February 27, 2009.

About the author:

IND Submissions: A Primer was written by Meredith Brown-Tuttle, RAC, a regulatory consultant whose background incorporates all aspects of drug, device, and biologics development including clinical research, data management, medical writing, and regulatory affairs. She served for six years on the Board of Editors for the Regulatory Affairs Professional Society's journal, "Focus," and has published numerous articles, edited books and book chapters, and presented at professional meetings on a variety of clinical research and regulatory topics. Ms. Brown-Tuttle also teaches about regulatory submissions, intelligence, strategy, and agency interactions for the Regulatory Affairs Certificate program at UC Santa Cruz.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Barnett International

Founded in 1979, Barnett International is widely recognized for its superior consulting services and its targeted education and training programs. Barnett helps clients get the most out of their research and development dollars by managing change effectively, improving organizational performance, and enhancing staff knowledge. The Barnett approach is a unique combination of strategy development and practical, hands-on implementation. The "Barnett Difference" is evident in our deep understanding of the clinical research process and in the rapid and tangible performance improvements we deliver.

We help pharmaceutical, biotechnology and medical device companies maximize the speed and quality of their product development efforts. With an international presence and with many staff members working from the client site for increased benefits, Barnett is able to apply a global expertise to its projects.

Our services include educational programs and products and consulting.

The source of our expertise:

  • Exclusively focused on the pharmaceutical/biopharmaceutical industry for more than 20 years
  • A team of talented professionals (150+) with deep-rooted industry insight and expertise
  • An in-depth understanding of different cultures and unique organizations
  • Experience working with major pharmaceutical companies around the world
  • Global resources with offices in the US and Europe

Media Contact:
Barnett International
Kate Bliss
Marketing Communications Manager
781-972-5435

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2184764.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
2. Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator
3. pMDsoft Releases Charge Capture Software for BlackBerry Storm
4. Teva Releases Second Video in Year of Affordable Healthcare Campaign
5. DaVita Releases Top Clinical Priorities for 2009
6. Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance
7. Moet & Chandon Releases Grand Vintage 1929 Magnum Commemorating First-Ever Academy Awards(R) To Benefit Motion Picture & Television Fund
8. PA DEP Releases Quarterly Mammography Inspections
9. Thomson Reuters Releases 2009 Patent Focus Report
10. Lumension Releases Annual Cybersecurity Report in Tandem with "Optimal Security" Blog Launch
11. Golden Meditech Releases FY2008/09 Q3 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change Medicare health ... is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their ... D) need to make changes during this period order for their new policy to ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... More than ... and while 84 percent of parents report speaking with their child about sex related ... sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its second ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the 5,000 ... unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition to ... been available in several ShopRite and FoodTown stores in NJ and received rave comments ...
(Date:12/2/2016)... Miami, FL (PRWEB) , ... December 02, 2016 ... ... over 5,100 hot meals to needy individuals and families from eight different sites ... Florida on Thanksgiving Day. Over 1,000 volunteers worked very hard on Thanksgiving morning ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... Braces & Support) is Expected to Gain a Significant Market ... to Orthopedic Ailments  ... , According to ... Study on Medical Implants Sterile Packaging: Clamshell Product Type Segment ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite and ... the Dow Jones Industrial Average managed to stay in green. ... which prompted Stock-callers this morning to look at the performances ... NUVA ), Smith & Nephew PLC (NYSE: SNN ... Cesca Therapeutics Inc. (NASDAQ: KOOL ). You can ...
(Date:12/2/2016)... -- The concept of rare diseases and the idea that ... has been taking shape in Europe ... initiatives related to orphan medicinal products have been emerging at ... states individually. Many member states in the EU have led ... medicinal products, the result of which took the shape of ...
Breaking Medicine Technology: